首页> 中文期刊> 《高等学校化学学报》 >N-取代肌肽酰胺类衍生物的合成及生物活性

N-取代肌肽酰胺类衍生物的合成及生物活性

         

摘要

A series of carnosine derivatives were synthesized by modification of primary amino groups of carnosine, eleven target compounds were obtained and characterized by NMR, UV-Vis and HR-MS. Acrolein scavenging activity test results showed that most compounds exhibited some acrolein scavenging activities, es-pecially compound 4k showed the highest acrolein scavenging activity which was stronger than carnosine. Spleen cell proliferation test results showed that most compounds exhibited some spleen cell proliferation activi-ties, compounds 4b, 4d and 4k showed stronger spleen cell proliferation activities than the positive control conA. Hydrogen peroxide injury pre-protection results showed that most compounds exhibited some pre-protec-tion effects, especially compounds 4a, 4j and 4k showed stronger ECV-304 cell pre-protection effects than carnosine. Plasma stability assay results showed that compared with carnosine, eleven compounds had good plasma stability.%以肌肽为原料,对伯氨基进行了结构修饰,合成了11种肌肽衍生物.化合物的结构经核磁共振、紫外-可见光谱及高分辨质谱分析确证.丙烯醛清除活性测试结果表明,在实验浓度下大部分化合物表现出一定的清除丙烯醛活性,尤其是化合物4k对丙烯醛的清除活性高于肌肽.脾细胞增殖活性测试结果表明,在实验浓度下大部分化合物表现出一定的脾细胞增殖活性,特别是化合物4b,4d和4k对脾细胞的增殖活性高于阳性对照伴刀豆球蛋白A.过氧化氢诱导血管内皮细胞损伤的预保护实验结果表明,在实验浓度下大部分化合物表现出一定的预保护作用,其中化合物4a,4j和4k对过氧化氢诱导血管内皮细胞损伤的预保护作用大于肌肽.血浆稳定性实验结果表明,与肌肽相比,11种化合物均具有很好的血浆稳定性.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号